2Comprehensive Pathophysiology Study Guide: Cellular Adaptation, Sensory Disorders, and Endocrine Dysfunction

Cerebral Atrophy

Pathophysiology Cerebral atrophy is characterized by a progressive reduction in the size of neurons and a subsequent reduction in the size of the cells within the cerebrum of the brain. This lead to a general shrinkage of brain tissue.

Etiology and Risk Factors

• Reduced Stimulation: Lack of cognitive or physical activity.

• Injury: Mechanical injury or Traumatic Brain Injury (TBI).

• Alzheimer's Disease: A primary neurodegenerative cause.

Signs and Symptoms

• Focal Effects: Manifestations are localized to a particular region of the brain.

• Global Effects: Manifestations affecting the entire brain.

• Cognitive Function: A notable decrease in cognitive function is observed.

Diagnostic and Lab Values

• Early Identification: Focusing on the loss of function.

• Health History (Hx): Detailed assessment of onset, duration, and severity.

• Neurologic Examination: Physical assessment of brain function.

• Imaging Studies: Visualization via CT, PET, MRI, and SPECT scans.

Treatment and Monitoring

• Cognitive Maintenance: Maximize cognitive function through intentional use of the brain.

• Disease Management: Interruption of the injury process and slowing the course of the disease to minimize continued pathology.

Nursing Functions

• Supportive Care: Assisting with activities of daily living (ADLs).

• Rehabilitation: Coordination with Physical, Speech, and Occupational Therapy to promote optimal function.

• Pharmacological Intervention: Administration of prescribed medications.

Cardiac Hypertrophy (Hypertrophic Cardiomyopathy)

Pathophysiology Cardiac hypertrophy involves an increased cardiac muscle mass due to an increase in myocardial cell size.

• Primary: An inherited non-sex linked genetic trait.

• Secondary: Caused by an underlying condition that increases the left ventricular workload, leading to an increase in left ventricular muscle mass.

Etiology

• Excessive Workload: Often resulting from Hypertension ($HTN$).

• Functional Demand: Increased demand on the heart.

• Genetic Trait: Inherited mutation; this is notably the most common cause of sudden unexpected death in athletes.

Signs and Symptoms Symptoms are variable and range from mild to severe:

• Shortness of breath (SOB).

• Chest pain.

• Syncope (fainting).

• Impaired cardiac function.

• Reduced exercise intolerance.

• Ventricular arrhythmia: Altered electrical signals in the ventricular cells.

• Heart murmur: Detected during physical examination.

Diagnostic and Lab Values

• Genetic Testing: Screening for genetic mutations and reviewing family history.

• Hypertension Assessment: Consistent monitoring of high blood pressure.

Other Diagnostic/Monitoring Procedures

• Electrocardiogram (ECG/EKG): Used to evaluate the electrical activity of the heart.

• 2-D Echocardiogram: Ultrasound measurement of the heart geometry and function.

• Exercise Stress Test: Determines the cardiovascular response to physical exertion.

Treatment

• Surgical: Physical intervention for structural corrections.

• Pharmacologic:     * Drugs that relax the ventricles.     * Drugs that reduce the workload of the heart and decrease the pressure that the heart must pump against.

• Non-pharmacologic: Activity restriction.

Acromegaly

Pathophysiology Acromegaly is a form of hyperpituitarism, a hormonal disorder involving excess Growth Hormone ($GH$) secretion which stimulates insulin-like growth factor 1 ($IGF-1$). This results in cellular hyperplasia and excessive growth of bones, cartilage, soft tissues, and organs.

• Timing: Crucially, this occurs AFTER the epiphyseal plate (growth plate) closure.

• Distinction: Note that Gigantism is the result of excess $GH$ BEFORE puberty.

• Presentation: An adult patient with $GH$ excess and enlarged hands or feet indicates Acromegaly.

Etiology In more than $90\%$ of cases, acromegaly is associated with a benign pituitary tumor known as an adenoma. The tumor causes a failed negative feedback system where $GH$ secretion is not reduced by the pituitary even as $IGF-1$ increases.

Signs and Symptoms

• Soft tissue swelling and altered facial features.

• Pain and numbness in the hands.

• Deepening of the voice and snoring.

• Skin changes and altered reproductive function.

• Joint pain.

• Glucose intolerance leading to Diabetes.

• Visual disturbances.

Diagnostic and Lab Values

• History and Physical Exam: Reviewing slow-developing symptoms in adulthood.

• Lab Analysis:     * Glucose Intolerance Test (due to insulin resistance).     * Growth Hormone levels.     * $IGF-1$ (insulin growth factor) levels.

Treatment

• Pharmacologic: Drugs to reduce hormone secretion.

• Non-pharmacologic: Radiation therapy to promote cell death in hypersecreting cells.

• Surgical: Removal of the pituitary adenoma.

Nursing Functions

• Monitoring: Checking for headaches and impaired vision (as the adenoma puts pressure on brain tissue).

• Assessments: Tracking cardiac status, glucose, vision, mobility, $GH$ levels, and joint pain.

• Alert: Be aware that hyperplastic changes can lead to cardiac hypertrophy and heart failure.

Cervical Metaplasia and Dysplasia

Pathophysiology of Metaplasia Cervical metaplasia is a cellular adaptation where squamous cells change to columnar epithelial cells (or vice versa) in the transformation zone of the cervix.

• Metaplasia Definition: A normal, protective, and reversible change of cell types in response to environmental stressors such as exposure to estrogen.

Pathophysiology of Dysplasia Cervical dysplasia is the abnormal growth and disordered differentiation in dividing cells.

• Dysplasia Definition: Occurs in the transformation zone because this area of squamous epithelium is highly sensitive to stressors.

Etiology

• Chronic infection, irritation, and trauma.

• Human Papillomavirus (HPV): The virus enters the host cell, integrates into the genome, and changes the cell DNA. High-risk strains are oncogenic.

Signs and Symptoms Typically, there are no clinical manifestations or signs/symptoms for either condition.

Risk Factors

1. Early onset of sexual activity.

2. Multiple ($3+$) sexual partners.

3. Exposure to HPV.

4. Smoking.

Diagnostic and Lab Values

• Pap Smears: Microscopic examination of transformation zone cells to detect changes.

• HPV Screening: To identify high-risk viral strains.

• Colposcopy: Biopsy of cervical tissue for microscopic examination if abnormalities are found.

Treatment

• Ablation: Removal of superficial cells via Cryosurgery (freezing), Laser ablation, Cold coagulation, Electrocoagulation, or Diathermy ablation.

• Surgical Excision: Hysterectomy may be required in cases of carcinoma.

Nursing Functions Patient education regarding screening schedules:

• Initial screening at age $21$.

• Ages $21-29$: Pap test alone every $3$ years.

• Ages $30-65$: Pap smear and HPV co-testing every $5$ years.

Fibromyalgia

Pathophysiology Fibromyalgia is a condition of the soft tissue and muscle characterized by significant pain and fatigue. There is no well-defined pathogenesis and no definitive evidence of muscle structural alterations or inflammation. It is likely linked to an epigenetic foundation (DNA methylation), neurophysiologic variables, and genetics. It occurs $7\times$ more often in women, typically seen in the $6th-7th$ decade of life.

Signs and Symptoms

• Heightened sensitivity to noxious stimuli.

• Full-body stiffness.

• Nonrestorative sleep and persistent fatigue.

• Difficulty in concentration ("fibro fog"), depression, and anxiety.

• Decreased serotonin levels.

• Alterations in brain structure, function, and cerebral blood flow.

Diagnostic and Lab Values

• Criteria: Pain must be present in $12$ of $18$ tender point sites for diagnosis.

• Trigger Points: Formation of "ropy bands" (tender, tight muscle fibers) that induce referred pain to other body parts.

• Condition Duration: Subjective findings of chronic pain and fatigue for at least $3$ months.

Treatment

• Symptom Management: Use of analgesics, antidepressants, anticonvulsants, and muscle relaxants.

• Common Combination: NSAID and Antidepressant combo.

• Therapy: Cognitive-behavioral therapy (CBT) and stress reduction methods.

Migraine Headache

Pathophysiology Meditating recurrent, moderate-to-severe headaches lasting $1-2$ days. It involves neurologic dysfunction of cortical, subcortical, and brainstem areas, leading to altered autonomic, affective, cognitive, and sensory function.

Etiology Most common in women. Approximately $40-50\%$ of Americans remain undiagnosed, and $40\text{ million}$ Americans are affected by migraine disorders.

Signs and Symptoms: The 4 Phases

1. Prodrome: Lasts a few hours to days before onset. Symptoms: mood changes, neck stiffness, yawning, food cravings, and constipation.

2. Aura: Lasts $5-60\,min$. Visual/sensory disturbances.

3. Headache: Lasts $4-72\,hrs$. Typically unilateral, pulsing, and throbbing. Accompanied by Nausea/Vomiting ($N/V$) and photosensitivity.

4. Postdrome: Lasts $24-48\,hrs$ after the headache subsides.

Diagnostic Criteria Diagnosis requires $5$ migraine episodes lasting $4-72\,hrs$.

• At least 2 characteristics: Unilateral, pulsating, moderate/severe, or associated with routine activity.

• At least 1 association: $N/V$, or sensitivity to light/sound.

Treatment

• Medications: Simple analgesics, triptans, ergots.

• Prophylaxis/Advanced: Botox every $12$ weeks for moderate-to-severe cases, Calcitonin gene-related peptide ($CGRP$) monoclonal antibodies (injectable protein), and Topiramate ($Topamax$).

Glaucoma

Pathophysiology

• Primary Open-Angle Glaucoma: Most common. Characterized by increased Intraocular Pressure ($IOP$) due to increased aqueous humor production and decreased outflow. The trabecular network becomes clogged.

• Angle-Closure Glaucoma (Acute): Less common but more severe. Caused by a rapid rise in $IOP$ from the blockage of aqueous humor by a narrowed/closed anterior chamber angle.

Etiology and Risk Factors

• Risk factors: Age over $60$, family history, diabetes, $HTN$, sickle cell anemia, eye trauma, and long-term steroid use.

• IOP Values: Normal is $14-16\,mmHg$. A value of $22\,mmHg+$ is considered abnormal.

Signs and Symptoms

• "Blind spots" beginning in the peripheral vision and progressing to central vision.

• Eye pain, headache, and nausea.

• Blurred vision and "rainbows" around lights at night.

Diagnostics

• Tonometry: Measures $IOP$.

• Ophthalmoscopy: Detects changes in the optic nerve.

• Visual Field Testing: Determines nerve damage.

• Snellen and Jaeger Eye Charts: For visual acuity assessment.

Treatment

• Pharmacologic:     * Miotics and Epinephrine-based drugs (increase outflow).     * Beta-blockers, Carbonic anhydrase inhibitors, and Alpha-adrenergic agonists (decrease fluid production).     * Prostaglandin analogs (increase secondary drainage).

• Surgical:     * Trabeculoplasty: Correction of trabecular network.     * Iridotomy: Incision into the iris for angle-closure.     * Cyclophotocoagulation: Reduction of fluid production via ciliary tissue correction.     * Trabeculotomy: Surgical removal of meshwork under the lid for new drainage.

Macular Degeneration (MD)

Pathophysiology MD affects the macula, causing central vision distortion or loss. It is the leading cause of blindness in older Americans.

• Dry MD (Atrophic): Most common. Slow progression. Characterized by retinal deterioration resulting from deposition of "drusen" (small yellow deposits) under the macula.

• Wet MD (Exudative): Less common but more severe/rapid. Involves new blood vessel formation (neovascularization) under the retina. Fluid leakage and bleeding distort the macula.

Signs and Symptoms

• Dry: Fluctuating vision, difficulty reading, and limited night vision.

• Wet: Dark central spots and rapid, severe vision loss.

Diagnostics

• Regular Eye Exams: Dilation for visualization of the retina/macula.

• Amsler Chart: Evaluation for vision changes.

• Fluorescein Angiography: Dye injection to detect abnormal fluid/vessels.

• Optical Coherence Tomography (OCT): Detailed retinal imaging.

Treatment

• Dry: Historically no treatment (though new studies report options in development).

• Wet: Intraocular drugs to block Vascular Endothelial Growth Factor ($VEGF$) to stop new vessel formation. Laser or photodynamic therapy is also used.

Otitis Media (OM)

Pathophysiology

• Acute Otitis Media (AOM): Infection of the middle ear/eustachian tubes. Common in febrile children; associated with Upper Respiratory Infection ($URI$) and inflammation.

• Otitis Media with Effusion (OME): Fluid in the middle ear without infection, resulting from obstruction.

Signs and Symptoms Pain, pressure, tinnitus, irritability, fever, tugging at ears, fluid drainage, loss of balance, and hearing difficulties.

Diagnostics and Lab Values

• Tympanometry: Measures movement of the tympanic membrane to identify fluid or perforation.

• Acoustic Reflex: Testing membrane response to sound.

• Bone Conduction Testing: Vibrator on forehead to stimulate the cochlear nerve.

• Hearing Loss Thresholds:     * Minimal: $16-25\,dB$     * Mild: $26-40\,dB$     * Moderate: $41-55\,dB$     * Severe: $71-90\,dB$     * Profound: $91+\,dB$

Meniere's Disease

Pathophysiology Altered vestibular function caused by swelling of the labyrinth component of the internal ear. This results in progressive degeneration of vestibular cochlear hair cells.

Signs and Symptoms

• Vertigo: The hallmark symptom; spinning sensation often with $N/V$.

• Nystagmus and Tinnitus.

• Sensory Fullness: Pain or feeling of fullness in the ear and sensorineural hearing loss.

Treatment

• Symptomatic: Betahistine (1st line), salt restriction, diuretics, and antinausea meds.

• Surgical: Vestibular neurectomy (severing the nerve) or Labyrinthectomy (removal of labyrinth; results in hearing loss).

Endocrine Imbalances: SIADH vs. DI

Syndrome of Inappropriate Antidiuretic Hormone (SIADH)

• Pathophysiology: Excess production/release of ADH leads to severe water retention ("Soaked Inside"). Sodium is diluted in the extracellular space.

• Etiology: Most commonly caused by a tumor secreting ectopic ADH.

• Diagnostics: Hypotonic hyponatremia (Serum Sodium $<135\,mEq/L$), plasma osmolality $<280\,mOsm/kg$, and concentrated urine.

• Symptoms: Concentrated/decreased urine, $HTN$, nausea, irritability, weakness, psychosis, seizures.

• Treatment: Remove cause (tumor), water restriction, and hypertonic IV fluid replacement if severe.

Diabetes Insipidus (DI)

• Pathophysiology: Insufficient ADH production or inadequate kidney response leads to an inability to retain water ("Dry Inside").

• Etiology: Brain injury, cranial surgery, or water intoxication.

• Symptoms: Polyuria (increased urination), pale urine, excessive thirst, dehydration, hypotension/shock.

• Diagnostics: Serum solute concentration, $ADH$ levels, and urine specific gravity tests.

• Treatment: Replace ADH, standard hydration, and pharmacologic treatment with Desmopressin (synthetic vasopressin).

Thyroid Dysfunction: Hyperthyroidism vs. Hypothyroidism

Hyperthyroidism (Example: Grave's Disease)

• Pathophysiology: excess thyroid hormone. Grave's is an autoimmune disorder where IgGs bind to TSH receptors, stimulates excessive hormone secretion.

• Signs: Goiter, weight loss, heat intolerance, tachycardia, tremors, and Exophthalmus (protruding eyeballs).

• Diagnostics: $TSH$ decreased; $T_3$ and $T_4$ increased.

• Treatment: Medications to block hormone production, radioactive iodine, or surgical removal.

Hypothyroidism (Example: Hashimoto's Disease)

• Pathophysiology: Deficient thyroid hormone due to autoimmunity, iodine deficiency, or gland destruction ("Sluggish").

• Signs: Fatigue, weight gain, cold intolerance, dry skin, and "myxedema" (swelling of skin/puffy face).

• Diagnostics: $TSH$ increased; Free $T_4$ decreased.

• Treatment: Lifelong thyroid hormone replacement therapy.

Adrenal Cortex Disorders: Cushing vs. Addison

Cushing Syndrome

• Pathophysiology: Overproduction of cortisol (glucocorticoids). Affects metabolic function and immunity.

• Etiology: Long-term exogenous steroids or tumors of the pituitary/adrenal glands.

• Signs: "Buffalo hump," "moon face," trunk obesity, thin extremities, and glucose intolerance.

• Note: Excess aldosterone leads to $HTN$ and hypokalemia; excess androgens lead to hirsutism.

Addison's Disease

• Pathophysiology: Autoimmune destruction of the adrenal cortex. Glands cannot produce glucocorticoids, mineralocorticoids, or androgens.

• Etiology: Disease presents when $90\%+$ of the cortex is destroyed.

• Signs: Darker skin pigmentation (high ACTH), hypoglycemia, hyponatremia, and hyperkalemia.

• Treatment: Lifelong cortisol replacement and increased sodium intake in the diet.

Inflammation and Immunity Conditions

Burns

• 1st Degree (Superficial partial thickness): Epidermis damage; heals in $1$ week (e.g., redness, pain).

• 2nd Degree (Deep partial thickness): Epidermis and some dermis; results in blistering; heals in $2-4$ weeks.

• 3rd Degree (Full thickness): Damage to epidermis, dermis, and subcutaneous layers; characterized by eschar (necrosis) and extensive scarring.

Rheumatoid Arthritis (RA)

• Pathophysiology: Chronic inflammation of synovial membranes leading to synovial hyperplasia and "Pannus formation." Results in cartilage erosion and ankylosis (stiffness).

• Diagnostics: Elevated ESR, CRP, Rheumatoid factor ($IgG$), and ANA.

Gastritis

• Acute: Result of irritating substances or poor perfusion; reversible if the agent is removed.

• Chronic: Often caused by Helicobacter pylori or autoimmunity; leads to mucosal cell atrophy and impaired acid production.

Pancreatitis

• Acute: Sudden onset. Injury to Acinar cells or pancreatic duct (e.g., gallstone obstruction or alcohol use).

• Chronic: Duct obstruction by enzymes and proteins; cells become atrophic and fibrotic. Symptoms include steatorrhea (fatty stools).

Inflammatory Bowel Disease (IBD)

• Crohn's Disease: Chronic inflammation anywhere in the GI tract (most common in the small intestine). Characterized by noncontinuous "skip lesions" and penetrating ulcerations.

• Ulcerative Colitis (UC): Chronic inflammation beginning in the rectum and ascending the colon. Characterized by continuous, superficial areas of ulceration.